THC Tenet Healthcare Corporation New

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * Andrews Audrey T.	2. Issuer Name and Ticker or Trading Symbol TENET HEALTHCARE CORP [ THC ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) EVP and General Counsel
(Last)          (First)          (Middle) 1445 ROSS AVENUE, SUITE 1400	3. Date of Earliest Transaction (MM/DD/YYYY) 8/23/2019
(Street) DALLAS, TX 75202 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock (1)	8/23/2019		M		11129	A	(2)	103411	D
Common Stock (3)	8/23/2019		M		37809	A	(2)	141220	D
Common Stock	8/23/2019		F		19258 (4)	D	$20.74	121962	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
2014 August Restricted Stock Units	(1)	8/23/2019		M			11129	(1)	(1)	Common Stock (5)	11129	$0.00	0	D
2014 August Performance-Based Restricted Stock Units	(3)	8/23/2019		M			37809	(3)	(3)	Common Stock (5)	37809	$0.00	0	D

Explanation of Responses:
(1)	As previously reported, on 8/25/14, the reporting person received a grant of 11,129 time-based restricted stock units that vest in their entirety on the fifth anniversary of the date of grant. The fifth anniversary occurred on 8/23/19 (the business day prior to the anniversary date, which fell on a weekend), resulting in the vesting and settlement of 11,129 shares of common stock, as shown in Table I.
(2)	Restricted stock units convert into common stock on a one-for-one basis.
(3)	On 8/25/14, the reporting person received a target grant of 22,260 performance-based restricted stock units, scheduled to vest on the fifth anniversary of the date of grant subject to the Company's attainment of specified performance goals and the level of achievement thereof. The performance goals were exceeded, and the award was certified at a payout of 37,809 units. The fifth anniversary occurred on 8/23/19 (the business day prior to the anniversary date, which fell on a weekend), resulting in the vesting and settlement of 37,809 shares of common stock, as shown in Table I.
(4)	Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
(5)	Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock upon vesting.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Andrews Audrey T. 1445 ROSS AVENUE SUITE 1400 DALLAS, TX 75202			EVP and General Counsel

Signatures
Mark R. Jackson, as Attorney-in-Fact for Audrey T. Andrews		8/27/2019
**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} Share on Facebook Share on Twitter Share on Email